Abstract
Lipidomics, a novel emerging “-omics” technology, focusing on identification and quantification of large-scale lipid molecules in organelle, cell, tissue and organism, provides a comprehensive lipid profile of sample instead of confined molecules and provokes insights into biomedical and healthy study. “-omics” technologies are getting widely used recently in the identification of biomarkers for diagnosis, prediction, and therapy of diseases, among which lipidomics mainly in lipid-related diseases. Besides, lipidomics also plays a role in translational medicine and other medical researches. Many vascular diseases like stenosis are lipid-related, so the application of this novel technology attracts our attention. Among those diseases, we will concentrate on the utility of lipidomics in carotid artery stenosis, of which usual pathology is atherosclerosis being wildly thought due to dyslipidemia. Furthermore, we will also evaluate the techniques used in lipidomics, the data analysis and its combination with other “-omics” technologies. Reflection on its present limitations and prospective in carotid stenosis study is also reviewed and conclusions which might promote further development of the lipidomics are drawn.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Acharjee A, Ament Z, West JA, Stanley E, Griffin JL. Integration of metabolomics, lipidomics and clinical data using a machine learning method. BMC Bioinform. 2016;17(Suppl 15):37–49. https://doi.org/10.1186/s12859-016-1292-2.
Alam R, Yatsu F, Tsui L, Alam S. Receptor-mediated uptake and ‘retroendocytosis’ of high-density lipoproteins by cholesterol-loaded human monocyte-derived macrophages: possible role in enhancing reverse cholesterol transport. Biochim Biophys Acta. 1989;1004(3):292–9.
Alewijnse A, Peters S. Sphingolipid signalling in the cardiovascular system: good, bad or both? Eur J Pharmacol. 2008;585(2–3):292–302.
Ansell B, Navab M, Hama S, Kamranpour N, Fonarow G, Hough G, Rahmani S, Mottahedeh R, Dave R, Reddy S, Fogelman A. Inflammatory/antiinflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favorably affected by simvastatin treatment. Circulation. 2003;108(22):2751–6.
Braverman N, Moser A. Functions of plasmalogen lipids in health and disease. Biochim Biophys Acta. 2012;1822(9):1442–52.
Brunham L, Kruit J, Iqbal J, Fievet C, Timmins J, Pape T, Coburn B, Bissada N, Staels B, Groen A, Hussain M, Parks J, Kuipers F, Hayden M. Intestinal ABCA1 directly contributes to HDL biogenesis in vivo. J Clin Invest. 2006;116(4):1052–62.
Byrdwell WC. Atmospheric pressure chemical ionization mass spectrometry for analysis of lipids. Lipids. 2001;36(4):327–46.
Calcagno C, Mulder WJ, Nahrendorf M, Fayad ZA. Recent highlights in ATVB: systems biology and non-invasive imaging of atherosclerosis. Arterioscler Thromb Vasc Biol. 2016;36(2):e1–8. https://doi.org/10.1161/atvbaha.115.306350.
Dang VT, Huang A, Zhong LH, Shi Y, Werstuck GH. Comprehensive plasma Metabolomic analyses of atherosclerotic progression reveal alterations in Glycerophospholipid and sphingolipid metabolism in apolipoprotein E-deficient mice. Sci Rep. 2016;6. https://doi.org/10.1038/srep35037.
Demetz E, Schroll A, Auer K, Heim C, Patsch J, Eller P, Theurl M, Theurl I, Theurl M, Seifert M, Lener D, Stanzl U, Haschka D, Asshoff M, Dichtl S, Nairz M, Huber E, Stadlinger M, Moschen A, Li X, Pallweber P, Scharnagl H, Stojakovic T, März W, Kleber M, Garlaschelli K, Uboldi P, Catapano A, Stellaard F, Rudling M, Kuba K, Imai Y, Arita M, Schuetz J, Pramstaller P, Tietge U, Trauner M, Norata G, Claudel T, Hicks A, Weiss G, Tancevski I. The arachidonic acid metabolome serves as a conserved regulator of cholesterol metabolism. Cell Metab. 2014;20(5):787–98. https://doi.org/10.1016/j.cmet.2014.09.004.
Dietz H, Cutting G, Pyeritz R, Maslen C, Sakai L, Corson G, Puffenberger E, Hamosh A, Nanthakumar E, Curristin S. Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature. 1991;352(6333):337–9.
Ekroos K, Jänis M, Tarasov K, Hurme R, Laaksonen R. Lipidomics: a tool for studies of atherosclerosis. Curr Atheroscler Rep. 2010;12(4):273–81. https://doi.org/10.1007/s11883-010-0110-y.
Fagerberg B, Ryndel M, Kjelldahl J, Akyürek L, Rosengren L, Karlström L, Bergström G, Olson F. Differences in lesion severity and cellular composition between in vivo assessed upstream and downstream sides of human symptomatic carotid atherosclerotic plaques. J Vasc Res. 2010;47(3):221–30.
Futerman A, Hannun Y. The complex life of simple sphingolipids. EMBO Rep. 2004;5(8):777–82.
Gao F, McDaniel J, Chen EY, Rockwell HE, Drolet J, Vishnudas VK, Tolstikov V, Sarangarajan R, Narain NR, Kiebish MA. Dynamic and temporal assessment of human dried blood spot MS/MSALL shotgun lipidomics analysis. Nutr Metab. 2017:14. https://doi.org/10.1186/s12986-017-0182-6.
Goldin A, Beckman J, Schmidt A, Creager M. Advanced glycation end products: sparking the development of diabetic vascular injury. Circulation. 2006;114(6):597–605.
Haase C, Frikke-Schmidt R, Nordestgaard B, Kateifides A, Kardassis D, Nielsen L, Andersen C, Køber L, Johnsen A, Grande P, Zannis V, Tybjaerg-Hansen A. Mutation in APOA1 predicts increased risk of ischaemic heart disease and total mortality without low HDL cholesterol levels. J Intern Med. 2011;270(2):136–46.
Han X, Yang K, Gross R. Multi-dimensional mass spectrometry-based shotgun lipidomics and novel strategies for lipidomic analyses. Mass Spectrom Rev. 2012;31(1):134–78.
Hannun Y, Obeid L. Principles of bioactive lipid signalling: lessons from sphingolipids. Nat Rev Mol Cell Biol. 2008;9(2):139–50.
Harris W, Mozaffarian D, Rimm E, Kris-Etherton P, Rudel L, Appel L, Engler M, Engler M, Sacks F. Omega-6 fatty acids and risk for cardiovascular disease: a science advisory from the American Heart Association Nutrition Subcommittee of the Council on Nutrition, Physical Activity, and Metabolism; Council on Cardiovascular Nursing; and Council on Epidemiology and Prevention. Circulation. 2009;119(6):902–7.
Hu C, Wang M, Han X. Shotgun lipidomics in substantiating lipid peroxidation in redox biology: methods and applications. Redox Biol. 2017;12:946–55. https://doi.org/10.1016/j.redox.2017.04.030.
Ingelsson E, Schaefer E, Contois J, McNamara J, Sullivan L, Keyes M, Pencina M, Schoonmaker C, Wilson P, D’Agostino R, Vasan R. Clinical utility of different lipid measures for prediction of coronary heart disease in men and women. JAMA. 2007;298(7):776–85.
Jacob SS, Hassan M, Yacoub MH. Utility of mass spectrometry for the diagnosis of the unstable coronary plaque. Glob Cardiol Sci Pract. 2015;2015(2). https://doi.org/10.5339/gcsp.2015.25.
Jeremy J, Gadsdon P, Shukla N, Vijayan V, Wyatt M, Newby A, Angelini G. On the biology of saphenous vein grafts fitted with external synthetic sheaths and stents. Biomaterials. 2007;28(6):895–908.
Kastelein J, van Leuven S, Burgess L, Evans G, Kuivenhoven J, Barter P, Revkin J, Grobbee D, Riley W, Shear C, Duggan W, Bots M. Effect of torcetrapib on carotid atherosclerosis in familial hypercholesterolemia. N Engl J Med. 2007;356(16):1620–30.
Kolovou G, Kolovou V, Mavrogeni S. Lipidomics in vascular health: current perspectives. Vasc Health Risk Manag. 2015;11:333–42. https://doi.org/10.2147/vhrm.s54874.
Kuivenhoven J, Pritchard H, Hill J, Frohlich J, Assmann G, Kastelein J. The molecular pathology of lecithin:cholesterol acyltransferase (LCAT) deficiency syndromes. J Lipid Res. 1997;38(2):191–205.
Laaksonen R, Jänis M, Oresic M. Lipidomics-based safety biomarkers for lipid-lowering treatments. Angiology. 2008;59(2 Suppl):65S–8S.
Langley SR, Willeit K, Didangelos A, Matic LP, Skroblin P, Barallobre-Barreiro J, Lengquist M, Rungger G, Kapustin A, Kedenko L, Molenaar C, Lu R, Barwari T, Suna G, Yin X, Iglseder B, Paulweber B, Willeit P, Shalhoub J, Pasterkamp G, Davies AH, Monaco C, Hedin U, Shanahan CM, Willeit J, Kiechl S, Mayr M. Extracellular matrix proteomics identifies molecular signature of symptomatic carotid plaques. J Clin Invest. 2017;127(4):1546–60. https://doi.org/10.1172/jci86924.
Lipids M. Apolipoproteins, and risk of vascular disease. JAMA. 2009;302(18):1993–2000. https://doi.org/10.1001/jama.2009.1619.
Lund-Katz S, Phillips M. High density lipoprotein structure-function and role in reverse cholesterol transport. Subcell Biochem. 2010;51:183–227.
Lynch M, Barallobre-Barreiro J, Jahangiri M, Mayr M. Vascular proteomics in metabolic and cardiovascular diseases. J Intern Med. 2016;280(4):325–38. https://doi.org/10.1111/joim.12486.
O’Donnell VB, Murphy RC, Watson SP. Platelet lipidomics: a modern day perspective on lipid discovery and characterization in platelets. Circ Res. 2014;114(7):1185–203. https://doi.org/10.1161/circresaha.114.301597.
Pagler T, Rhode S, Neuhofer A, Laggner H, Strobl W, Hinterndorfer C, Volf I, Pavelka M, Eckhardt E, van der Westhuyzen D, Schütz G, Stangl H. SR-BI-mediated high density lipoprotein (HDL) endocytosis leads to HDL resecretion facilitating cholesterol efflux. J Biol Chem. 2006;281(16):11193–204.
Pfisterer L, König G, Hecker M, Korff T. Pathogenesis of varicose veins – lessons from biomechanics. Vasa. 2014;43(2):88–99.
Rasmiena A, Barlow C, Stefanovic N, Huynh K, Tan R, Sharma A, Tull D, de Haan J, Meikle P. Plasmalogen modulation attenuates atherosclerosis in ApoE- and ApoE/GPx1-deficient mice. Atherosclerosis. 2015;243(2):598–608.
Salazar J, Olivar LC, Ramos E, Chávez-Castillo M, Rojas J, Bermúdez V. Dysfunctional high-density lipoprotein: an innovative target for proteomics and lipidomics. Cholesterol. 2015;2015. https://doi.org/10.1155/2015/296417.
Santos A, Fonseca F, Fischer S, Monteiro C, Brandão S, Póvoa R, Bombig M, Carvalho A, Monteiro A, Ramos E, Gidlund M, Figueiredo Neto A, Izar M. High circulating autoantibodies against human oxidized low-density lipoprotein are related to stable and lower titers to unstable clinical situation. Clin Chim Acta. 2009;406(1–2):113–8.
Sergent O, Ekroos K, Lefeuvre-Orfila L, Rissel M, Forsberg G, Oscarsson J, Andersson T, Lagadic-Gossmann D. **melagatran increases membrane fluidity and changes membrane lipid composition in primary human hepatocytes. Toxicol In Vitro. 2009;23(7):1305–10.
Serhan C. Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways. Annu Rev Immunol. 2007;25:101–37.
Sun B, Eckhardt E, Shetty S, van der Westhuyzen D, Webb N. Quantitative analysis of SR-BI-dependent HDL retroendocytosis in hepatocytes and fibroblasts. J Lipid Res. 2006;47(8):1700–13.
Surma MA, Herzog R, Vasilj A, Klose C, Christinat N, Morin-Rivron D, Simons K, Masoodi M, Sampaio JL. An automated shotgun lipidomics platform for high throughput, comprehensive, and quantitative analysis of blood plasma intact lipids. Eur J Lipid Sci Technol. 2015;117(10):1540–9. https://doi.org/10.1002/ejlt.201500145.
Tarasov K, Ekroos K, Suoniemi M, Kauhanen D, Sylvänne T, Hurme R, Gouni-Berthold I, Berthold HK, Kleber ME, Laaksonen R, März W. Molecular lipids identify cardiovascular risk and are efficiently lowered by simvastatin and PCSK9 deficiency. J Clin Endocrinol Metab. 2014;99(1):E45–52. https://doi.org/10.1210/jc.2013-2559.
Tonks K, Coster A, Christopher M, Chaudhuri R, Xu A, Gagnon-Bartsch J, Chisholm D, James D, Meikle P, Greenfield J, Samocha-Bonet D. Skeletal muscle and plasma lipidomic signatures of insulin resistance and overweight/obesity in humans. Obesity (Silver Spring). 2016;24(4):908–16.
Tumanov S, Kamphorst JJ. Recent advances in expanding the coverage of the lipidome. Curr Opin Biotechnol. 2017;43:127–33. https://doi.org/10.1016/j.copbio.2016.11.008.
Wang M, Fang H, Han X. Shotgun lipidomics analysis of 4-hydroxyalkenal species directly from lipid extracts after one-step in situ derivatization. Anal Chem. 2012;84(10):4580–6.
Wang M, Han R, Han X. Fatty acidomics: global analysis of lipid species containing a carboxyl group with a charge-remote fragmentation-assisted approach. Anal Chem. 2013;85(19):9312–20.
Zannis V, Chroni A, Krieger M. Role of apoA-I, ABCA1, LCAT, and SR-BI in the biogenesis of HDL. J Mol Med. 2006;84(4):276–94.
Zheng W, Kollmeyer J, Symolon H, Momin A, Munter E, Wang E, Kelly S, Allegood J, Liu Y, Peng Q, Ramaraju H, Sullards M, Cabot M, Merrill A. Ceramides and other bioactive sphingolipid backbones in health and disease: lipidomic analysis, metabolism and roles in membrane structure, dynamics, signaling and autophagy. Biochim Biophys Acta. 2006;1758(12):1864–84.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Zhang, W., Zhou, X., Guo, D., Fu, W., Wang, L. (2018). Lipidomics in Carotid Artery Stenosis: Further Understanding of Pathology and Treatment. In: Wang, X., Wu, D., Shen, H. (eds) Lipidomics in Health & Disease. Translational Bioinformatics, vol 14. Springer, Singapore. https://doi.org/10.1007/978-981-13-0620-4_5
Download citation
DOI: https://doi.org/10.1007/978-981-13-0620-4_5
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-0619-8
Online ISBN: 978-981-13-0620-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)